BRAF, as a component in MAPK/ERK signal pathway, is commonly found to mutate in quite a few malignancies, and BRAF inhibitors were discovered to be useful in increasing TILs in mouse and human melanoma.60, 61. This evidence concerns the gene BRAF and melanoma.